Nature Biotechnology

    Title / AuthorCited byYear
    Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
    M Nakagawa, M Koyanagi, K Tanabe, K Takahashi, T Ichisaka, T Aoi, ...
    Nature Biotechnology 26 (1), 101-106
    11502007
    Next-generation DNA sequencing
    J Shendure, H Ji
    Nature Biotechnology 26 (10), 1135-1145
    9762008
    The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration
    B Smith, M Ashburner, C Rosse, J Bard, W Bug, W Ceusters, LJ Goldberg, ...
    Nature Biotechnology 25 (11), 1251-1255
    7152007
    Isolation of amniotic stem cell lines with potential for therapy
    P De Coppi, G Bartsch, MM Siddiqui, T Xu, CC Santos, L Perin, ...
    6362007
    A quantitative analysis of kinase inhibitor selectivity
    MW Karaman, S Herrgard, DK Treiber, P Gallant, CE Atteridge, ...
    Nature Biotechnology 26 (1), 127-132
    6062008
    Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts
    MA Laflamme, KY Chen, AV Naumova, V Muskheli, JA Fugate, SK Dupras, ...
    Nature Biotechnology 25 (9), 1015-1024
    5942007
    Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2
    D Huangfu, K Osafune, R Maehr, W Guo, A Eijkelenboom, S Chen, ...
    Nature Biotechnology 26 (11), 1269-1275
    5502008
    Renal clearance of quantum dots
    HS Choi, W Liu, P Misra, E Tanaka, JP Zimmer, BI Ipe, MG Bawendi, ...
    Nature Biotechnology 25 (10), 1165-1170
    5372007
    In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
    X Qian, XH Peng, DO Ansari, Q Yin-Goen, GZ Chen, DM Shin, L Yang, ...
    Nature Biotechnology 26 (1), 83-90
    5192007
    Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
    A Meissner, M Wernig, R Jaenisch
    Nature Biotechnology 25 (10), 1177-1181
    4912007
    MaxQuant enables high peptide identification rates, individualized ppb-range mass accuracies and proteome-wide protein quantification
    J Cox, M Mann
    Nature Biotechnology 26 (12), 1367-1372
    4882008
    Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds
    D Huangfu, R Maehr, W Guo, A Eijkelenboom, M Snitow, AE Chen, ...
    Nature Biotechnology 26 (7), 795-797
    4872008
    Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
    T Aasen, A Raya, MJ Barrero, E Garreta, A Consiglio, F Gonzalez, ...
    Nature Biotechnology 26 (11), 1276-1284
    4412008
    Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo
    E Kroon, LA Martinson, K Kadoya, AG Bang, OG Kelly, S Eliazer, H Young, ...
    Nature Biotechnology 26 (4), 443-452
    4342008
    Characterization of human embryonic stem cell lines by the International Stem Cell Initiative
    O Adewumi, B Aflatoonian, L Ahrlund-Richter, M Amit, PW Andrews, ...
    Nature Biotechnology 25 (7), 803-816
    4252007
    Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation.
    P Lu, C Vogel, R Wang, X Yao, EM Marcotte
    Nature biotechnology 25 (1), 117
    4082007
    A ROCK inhibitor permits survival of dissociated human embryonic stem cells
    K Watanabe, M Ueno, D Kamiya, A Nishiyama, M Matsumura, T Wataya, ...
    Nature Biotechnology 25 (6), 681-686
    4082007
    The potential and challenges of nanopore sequencing
    D Branton, DW Deamer, A Marziali, H Bayley, SA Benner, T Butler, ...
    Nature Biotechnology 26 (10), 1146-1153
    3932008
    Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug
    PA Marks, R Breslow
    Nature Biotechnology 25 (1), 84-90
    3602007
    Drug-target network.
    MA Yildirim, KI Goh, ME Cusick, AL Barabási, M Vidal
    Nature biotechnology 25 (10), 1119
    3462007
    1 - 20